MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-GJ-01-0061151
Meteoric Biopharmaceuticals Private Limited - chemicals and materials in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹126 Cr
▲ 21% YoY
Net profit · FY 2025
₹8.4 Cr
Net margin 6.7%
EBITDA · FY 2025
₹14.6 Cr
EBITDA margin 11.6%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.5 Cr
Issued & subscribed
Open charges
₹45.15 Cr
Satisfied ₹3.5 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
77
Provident fund records
About Meteoric Biopharmaceuticals Private Limited
Data last updated:
Meteoric Biopharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the industrial enzymes and biochemicals segment of the chemicals and materials sector. It was incorporated on 13 April 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51100GJ2006PTC048129. Its GSTIN is 24AAECM6242M1ZB (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.5 Cr. It was formerly known as Meteoric Exim Private Limited. It is led by directors Poonam Kailash Gupta and Gaurav Kaushik.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 901 – 904 9th Floor Earth Arise S G Highway Makarba Ahmedabad – 380015, Gujarat, India – 380015.
As per the financials filed for FY 2025, the company reported a revenue of ₹126 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹8.4 Cr (net margin 6.7%) and EBITDA of ₹14.6 Cr (EBITDA margin 11.6%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 24% over five years.
The company has about 77 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Meteoric Biopharmaceuticals. As per MCA filings, the company has open charges of ₹45.15 Cr and satisfied charges of ₹3.5 Cr on record. Court records list 47 cases involving the company, including 34 filed by the company and 13 filed against it; 18 cases are pending. The company has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.47 Cr; the latest was in January 2024. The company has 3 MSME Form 1 returns on record for the period ending Sep 2019, listing 50 overdue payments to 3 micro and small suppliers.
Meteoric Biopharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0061151). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website meteoricbiopharma.com.
Company details
CIN U51100GJ2006PTC048129
Registration Number 048129
Incorporation Date 13 April 2006
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-GJ-01-0061151
CIN history
Meteoric Biopharmaceuticals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U51100GJ2006PTC048129, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51100GJ2006PTC048129 | Current |
| U52100GJ2006PLC048129 | Previous |
| U52100GJ2006PTC048129 | Previous |
Recognitions & Rankings of Meteoric Biopharmaceuticals
Contact details
Meteoric Biopharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its website is meteoricbiopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address901 – 904 9th Floor Earth Arise S G Highway Makarba Ahmedabad – 380015, Gujarat, India – 380015
- IndustryChemicals and Materials, Industrial Enzymes & Biochemicals
To see the full contact details of Meteoric Biopharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Meteoric Biopharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Meteoric Biopharmaceuticals operates one associated brand: Meteoric Biopharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops enzymes, probiotics, and formulations for health and industrial applications. | meteoricbiopharma.com |
Business activity
The main business activity of Meteoric Biopharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Meteoric Biopharmaceuticals Private Limited, buy the company report.
Financials of Meteoric Biopharmaceuticals Private Limited
FY 2025 filings availableMeteoric Biopharmaceuticals Private Limited reported revenue of ₹126 Cr (up 21% YoY) for FY 2025.
Revenue · FY 2025
₹126 Cr ▲ 21%
Net profit · FY 2025
₹8.4 Cr margin 6.7%
EBITDA · FY 2025
₹14.6 Cr margin 11.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 8%
5 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▲ 78%
3 years · compounded
▲ 31%
5 years · compounded
▲ 53%
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 21% growth in the latest year. EBITDA rose 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.6 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.4 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.6% | ||||
| Net Profit Margin | 6.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Meteoric Biopharmaceuticals Private Limited, buy the company report.
Board of directors of Meteoric Biopharmaceuticals Private Limited
Meteoric Biopharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poonam Kailash Gupta | Director | 02 Jan 2019 | 7 Years 9 Months | Current |
| Gaurav Kaushik | Director | 30 Jun 2009 | 17 Years 3 Months | Current |
Auditor
Meteoric Biopharmaceuticals Private Limited is audited by JAYMIN SHAH & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAYMIN SHAH & ASSOCIATES | FY 2023 | 129406W |
Shareholding
The shareholding of Meteoric Biopharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Meteoric Biopharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹45.15 Cr
Satisfied charges
₹3.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Apr 2024 | 100909896 | Axis Bank Limited | ₹45.15 Cr | Open | |
| 20 Nov 2021 | 100501202 | Others | ₹1.5 Cr | Satisfied | |
| 21 Oct 2021 | 100491251 | Sidbi | ₹2 Cr | Satisfied |
To see the full charge records of Meteoric Biopharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Meteoric Biopharmaceuticals Private Limited has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.47 Cr; the latest was in January 2024.
Total deals
6
Secondary share transfers
4
Funding rounds
2
Disclosed funding
₹1.47 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2021 | Funding round | ₹1.4 Cr | Investors: 2 individuals |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2016 | Funding round | ₹6.8 Lakh | Investors: an individual |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
To see the full deal history of Meteoric Biopharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Meteoric Biopharmaceuticals Private Limited has 47 court cases on record: 34 filed by Meteoric Biopharmaceuticals, 13 filed against it. 18 cases are pending and 29 are disposed.
Total cases
47
Filed by the company
34
Filed against the company
13
Pending
18
Disposed
29
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 43 | 10 | 18 |
| High courts | 4 | 3 | 0 |
Cases on record (5 of 47)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by M/S Vijayalakshmi Industries Private Limited | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed by the company against Biodeal Pharmaceuticals Ltd and 6 others | Pending |
| District court, Ahmedabad, Gujarat | Court case (SMST R) | Filed by the company against Neiss Labs Limited and 2 others | Pending |
| District court, Ahmedabad, Gujarat | Court case (SMST R) | Filed by the company against Aumgene Biosciences Pvt. Ltd. | Pending |
| District court, Ahmedabad, Gujarat | Commercial matter | Filed by the company against Progressive Dairy Solutions Ltd. and 1 other | Disposed |
To see the full case history of Meteoric Biopharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Meteoric Biopharmaceuticals Private Limited has 3 MSME Form 1 returns on record for the period ending Sep 2019, listing 50 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| West Bengal Chemical Industries Ltd. | |||
| an individual supplier |
To see the full MSME payment records of Meteoric Biopharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Meteoric Biopharmaceuticals Private Limited has a workforce of 77 employees on its EPFO records as of Oct 06, 2024, across 1 active EPFO establishment.
Employee count
77
Active EPFO establishments
1
Employee growth
6.94%
GST
Meteoric Biopharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECM6242M1ZB | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Meteoric Biopharmaceuticals Private Limited, buy the company report.
Recent activity
Meteoric Biopharmaceuticals Private Limited has 6 board changes on record since 2009: 2 appointments and 4 cessations. The latest: Kunjal Harshvadanbhai Patel ceased to be Director on 30 Jun 2023.
AGM
Meteoric Biopharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited of Rs. 45.15 Cr registered on 03 Apr 2024 with Charge ID 100909896 was modified on 13 May 2025.
Filing
Meteoric Biopharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Axis Bank Limited amounted to Rs. 45.15 Cr with Charge ID 100909896 was registered on 03 Apr 2024.
Charges
A charge registered on 20 Nov 2021 via Charge ID 100501202 with Others was fully satisfied on 15 Feb 2024.
Ceased
Kunjal Harshvadanbhai Patel ceased to be Director.
Charges
A charge registered on 21 Oct 2021 via Charge ID 100491251 with Sidbi was fully satisfied on 21 Apr 2023.
Charges
A charge with Others of Rs. 1.50 Cr registered on 20 Nov 2021 with Charge ID 100501202 was modified on 23 Nov 2021.
Charges
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 100501202 was registered on 20 Nov 2021.
Charges
A charge with Sidbi amounted to Rs. 2.00 Cr with Charge ID 100491251 was registered on 21 Oct 2021.
Appointed
Poonam Kailash Gupta was appointed as Director.
Ceased
Poonam Kailash Gupta ceased to be Director.
4 earlier events are in the company report.
Frequently asked questions
Meteoric Biopharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in industrial enzymes and biochemicals, within the chemicals and materials industry. It was incorporated on 13 April 2006 (20+ years old) and is registered under CIN U51100GJ2006PTC048129.
Meteoric Biopharmaceuticals has 2 current directors:
- Poonam Kailash Gupta - Director
- Gaurav Kaushik - Director
The latest financial statements of Meteoric Biopharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Meteoric Biopharmaceuticals is 24AAECM6242M1ZB, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Meteoric Biopharmaceuticals is U51100GJ2006PTC048129. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meteoric Biopharmaceuticals has 47 court cases on record: 34 filed by the company and 13 filed against it. 18 are pending. Most are in the district courts.
Meteoric Biopharmaceuticals was incorporated on 13 April 2006, making it 20+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Meteoric Biopharmaceuticals has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.47 Cr; the latest was in January 2024.
Kunjal Harshvadanbhai Patel ceased to be Director on 30 Jun 2023. Poonam Kailash Gupta was appointed as Director on 02 Jan 2019. Poonam Kailash Gupta ceased to be Director on 14 Oct 2013. Meteoric Biopharmaceuticals has 6 board changes on record in total.
Yes, Meteoric Biopharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-GJ-01-0061151).
Meteoric Biopharmaceuticals has 3 MSME Form 1 returns on record for the period ending Sep 2019, listing 50 overdue payments to 3 micro and small suppliers. The latest return was filed on 08 Dec 2019.